Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort

Luca Gianni, Wolfgang EIERMANN, Владимир Федорович Семиглазов et al. · The Lancet · 2010

Cited by 1,255 works. doi:10.1016/s0140-6736(09)61964-4

Authors

References